Northern Trust’s Matinas BioPharma MTNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-1,506
| Closed | -$42.7K | – | 4517 |
|
|
2025
Q3 | $42.7K | Buy |
+1,506
| New | +$32.5K | ﹤0.01% | 4301 |
|
|
2024
Q3 | – | Sell |
-574
| Closed | -$68.1K | – | 4436 |
|
|
2024
Q2 | $68.1K | Hold |
574
| – | – | ﹤0.01% | 4143 |
|
|
2024
Q1 | $117K | Buy |
574
+91
| +19% | +$16.2K | ﹤0.01% | 4036 |
|
|
2023
Q4 | $78.3K | Hold |
483
| – | – | ﹤0.01% | 4158 |
|
|
2023
Q3 | $47.1K | Hold |
483
| – | – | ﹤0.01% | 4182 |
|
|
2023
Q2 | $130K | Sell |
483
-2
| -0.4% | -$699 | ﹤0.01% | 3965 |
|
|
2023
Q1 | $171K | Buy |
485
+23
| +5% | +$8.72K | ﹤0.01% | 3913 |
|
|
2022
Q4 | $173K | Hold |
462
| – | – | ﹤0.01% | 3930 |
|
|
2022
Q3 | $220K | Buy |
462
+38
| +9% | +$22.4K | ﹤0.01% | 3835 |
|
|
2022
Q2 | $251K | Hold |
424
| – | – | ﹤0.01% | 3806 |
|
|
2022
Q1 | $256K | Sell |
424
-17
| -4% | -$9.38K | ﹤0.01% | 4030 |
|
|
2021
Q4 | $334K | Hold |
441
| – | – | ﹤0.01% | 3975 |
|
|
2021
Q3 | $430K | Buy |
441
+12
| +3% | +$7.77K | ﹤0.01% | 3821 |
|
|
2021
Q2 | $250K | Hold |
429
| – | – | ﹤0.01% | 4059 |
|
|
2021
Q1 | $338K | Buy |
429
+62
| +17% | +$62.4K | ﹤0.01% | 3940 |
|
|
2020
Q4 | $374K | Sell |
367
-7
| -2% | -$4.86K | ﹤0.01% | 3796 |
|
|
2020
Q3 | $215K | Sell |
374
-2
| -0.5% | -$1.19K | ﹤0.01% | 3804 |
|
|
2020
Q2 | $218K | Sell |
376
-24
| -6% | -$13.8K | ﹤0.01% | 3738 |
|
|
2020
Q1 | $180K | Buy |
400
+82
| +26% | +$74.3K | ﹤0.01% | 3704 |
|
|
2019
Q4 | $542K | Buy |
318
+2
| +0.6% | +$1.74K | ﹤0.01% | 3538 |
|
|
2019
Q3 | $149K | Hold |
316
| – | – | ﹤0.01% | 3835 |
|
|
2019
Q2 | $203K | Buy |
316
+73
| +30% | +$52.6K | ﹤0.01% | 3821 |
|
|
2019
Q1 | $198K | Sell |
243
-1
| -0.4% | -$808 | ﹤0.01% | 3784 |
|
|
2018
Q4 | $109K | Buy |
244
+39
| +19% | +$23K | ﹤0.01% | 3901 |
|
|
2018
Q3 | $141K | Hold |
205
| – | – | ﹤0.01% | 3953 |
|
|
2018
Q2 | $67K | Sell |
205
-670
| -77% | -$290K | ﹤0.01% | 4078 |
|
|
2018
Q1 | $502K | Buy |
875
+24
| +3% | +$19K | ﹤0.01% | 3566 |
|
|
2017
Q4 | $741K | Sell |
851
-11
| -1% | -$10.6K | ﹤0.01% | 3479 |
|
|
2017
Q3 | $854K | Buy |
862
+90
| +12% | +$90.1K | ﹤0.01% | 3470 |
|
|
2017
Q2 | $980K | Buy |
+772
| New | +$1.55M | ﹤0.01% | 3448 |
|
Other funds holding MTNB
HIW
Northern Trust's MTNB Position: Q4 2025 in Review
Northern Trust sold out of Matinas BioPharma (MTNB) in Q4 2025, closing a stake of 1,506 shares — an estimated $42.7K sold.
Northern Trust first reported a position in MTNB in Q2 2017 and held it in 30 quarters. The position peaked at $980K in Q2 2017. 28 funds tracked by Wall St. Rank hold MTNB as of Q4 2025.
- Northern Trust reported no remaining Matinas BioPharma position as of Q4 2025 after selling out during the quarter.
- Northern Trust sold 1,506 Matinas BioPharma shares in Q4 2025, an estimated $42.7K.
- Northern Trust first reported a position in Matinas BioPharma in Q2 2017 and held it in 30 quarters.
- Northern Trust's Matinas BioPharma position peaked at $980K in Q2 2017.
- 28 funds tracked by Wall St. Rank held Matinas BioPharma as of Q4 2025.
Based on Northern Trust's 13F filing for Q4 2025, filed 17 Feb 2026.